Flow cytometric detection of circulating activated platelets in primary antiphospholipid syndrome. Correlation with thrombocytopenia and anticardiolipin antibodies

Lupus

Volumn 6, Issue 3, 1997, Pages 261-267

  Fanelli, A ^a   Bergamini, C ^b   Rapi, S ^a   Caldini, A ^a   Spinelli, A ^b   Buggiani, A ^a   Emmi, L ^a,b  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Anticardiolipin antibodies; Antiphospholipid syndrome; Flow cytometry; Platelet activation; Thrombocytopenia

Indexed keywords

CARDIOLIPIN ANTIBODY; CD63 ANTIGEN; GLYCOPROTEIN; LUPUS ANTICOAGULANT; PADGEM PROTEIN; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 0030892844     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339700600309     Document Type: Article

References (36)

1. Harris EN, Baguley E, Hasherson RA, Hughes GRV. Clinical and serological features of the antiphospholipid syndrome. Br J Rheumatol 1987; 26: 19-21
2. Vela P, Batlle E, Salas E, Marco P, Primary antiphospholipid syndrome and osteonecrosis. Clin Exp Rheumatol 1991; 9 545-546
3. Hugson MD et al. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome Am J Kid Dis 1992; 20: 150-158.
4. Luchi M, Asherson RA, Lahita RG Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis. Arthritis Rheum 1992; 35: 700-705.
5. Aron AL, Gharavi AE, Shoefeld Y. Mechanisms of action of antiphospholipid antibodies in the antiphospholipid syndrome. Intern Arch Allergy Immunol 1995; 106: 8-12.
6. Zwaal RFA, Comfurius P, Bevers EM Platelet procoagulant activity and microvesicle formation Its putative role in hemostasis and thrombosis. Block Biophys Acta 1992; 1180: 1-8.
7. Bevers EM et al. Lupus Anticoagulant IgG's (LA) are not directed to phospholipids only but to a complex of lipid-bound human prothrombin. Thromb Haemostas 1991; 66: 629-632.
8. Galli M et al. Anticardiolipin antibodies (ACA) directed not to cardiohpin but to a plasma protein cofactor. Lancet 1990; 335: 1544-1547
9. Galli M et al. Anticoagulant activity of anticardiolipin antibodies is mediated by β2-glycoprotein I. Thromb Haemostas 1992; 68: 297-300.
10. Galli M et al. Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles. Br J Haematol 1993; 83: 466-472.
11. Shi W, Chong BH, Chesterman CN β2-glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets, differences with lupus anticoagulants. Blood 1993; 81: 1255-1262.
12. Vazquez-Mellado J, Llorente L, Richaud-Patin Y, Alarcon-Segovia D. Exposure of anionic phospholipids upon platelet activation permits binding of β2-glycoprotein I and through it that of IgG antiphosphohpid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects J Autoimmun 1994; 7: 335-348.
13. Brighton TA, Chesterman CN. Antiphospholipid antibodies and thrombosis. In Meade TW (ed). Clinical Haematology: Thrombophylia, Bailliere Tindall WB, Saunders Co Ltd, London, UK 1994, pp 541-557
14. Shattil SJ, Cunningham M, Hoxie JA Detecton of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987; 70: 307-315
15. Abrams CS, Ellison N, Budzynski AZ. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990, 75: 128-138.
16. McEver RP. Properties of GMP-140, an inducible granule membrane protein of platelets and endothelium Blood cells 1990; 16: 73-83.
17. Nieuwenhuis K et al. Studies with a monoclonal antibodies against activated platelets. Evidence that a secreted 53 000 molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in circulation. Blood 1987; 70: 838-845.
18. Metzelaar MJ, Sixma J, Nieuwenhuis K. Detection of platelet activation using activation specific monoclonal antibodies. Blood cells 1990; 16: 85-96.
19. Corash L. Measurement of platelet activation by fluorescence-activated flow cytometry Blood cells 1990; 16: 97-108.
20. Abrams C, Shattil SJ. Immunological detection of activated platelets in clinical disorders. Thromb Haemostast 1991; 5: 467-473.
21. Wehmeier A et al. Circulating activated platelets in myeloproliferative disorders. Thromb Res 1991; 61: 271-278.
22. Metzelaar MJ, Korteweg J, Sixma JJ, Nieuwenhuis K Comparison of platelet membrane markers for the detection of platelets activation in vitro and during platelets storage and cardiopulmonary bypass surgery. J Lab Clin Med 1993; 121: 579-587.
23. Tschoepe D et al. Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation 1993; 88: 37-42.
24. Gralnick HR et al. Activated platelets in paroxysmal nocturnal hemoglobinuria. Br J Haematol 1995; 91: 697-702.
25. Out JH et al. Antibodies to platelets in patients with anti-phospholipid antibodies. Blood, 1991; 77: 2655-2659
26. Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1271.
27. Alarcon Segovia D Antiphospholipid syndrome within systemic lupus erithematosus Lupus 1994; 3(4) 289-291
28. Harris EN et al Anticardiolipin antibodies detection by radio-immunoassay and association with thrombosis in SLE. Lancet 1983; 3: 1211-1214.
29. Tincani A et al Antiphospholipid and antimithocondrial type M5 antibodies in SLE Ex Rheumatol 1988; 3 321-325.
30. McEver RP, Martin NM. A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J Biol Chem 1984; 259: 9799-9804
31. George JN, Pickett EB, Saucermann S Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 1986; 78: 340-345.
32. George JN, Pickett EB, Heinz R. Platelet membrane gylcoprotein changes during the preparation and storage of platelets concentrates. Transfusion 1988 28: 123-126.
33. Ault KA, Mitchell J. Analysis of platelets by flow cytometry. Methods Cell Biol 1994, 42: 275-295.
34. Arvieux J et al. Lupus-like anticoagulant properties of murine monoclonal antibodies to β2-glycoprotein I. Haematol 1992; 81: 568-573.
35. Branch DW, Rodgers GM Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome. a possible mechanism of thrombosis. Am J Obs and Gynecol 1993; 168: 206-210.
36. Yuh-Ling L, Cheng-Teh W. Activation of human platelets by the rabbit anticardiolipin antibodies. Blood 1992; 80 3135-3143.